Search Results

Filter
  • 1-5 of  5 results for ""Cyclic Nucleotide Phosphodiesterases, Type 3""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast.

  • Authors : Kroegel C; Medical Clinic I, Department of Pneumology and Allergy, Friedrich-Schiller-University, Erlanger Allee 101, D-07740 Jena, Germany. ; Foerster M

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Drugs, Investigational/Drugs, Investigational/Drugs, Investigational/*therapeutic use ; Nitriles/Nitriles/Nitriles/*therapeutic use

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2007 Jan; Vol. 16 (1), pp. 109-24.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Internet ISSN: 1744-7658

Record details

×
Academic Journal

Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.

  • Authors : Stehlik J; University of Utah School of Medicine, Cardiology Section, VA Salt Lake City Healthcare System, 500 Foothill Boulevard, Salt Lake City, UT 84117, USA. ; Movsesian MA

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; 3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/*antagonists & inhibitors ; Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*therapeutic use

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2006 Jul; Vol. 15 (7), pp. 733-42.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Internet ISSN: 1744-7658

Record details

×
Academic Journal

The therapeutic potential of novel cardiotonic agents.

  • Authors : Endoh M; Department of Pharmacology, Yamagata University School of Medicine, 2-2-2 Iida-nishi, Yamagata, 990-9585 Japan.

Subjects: Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy; 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2003 May; Vol. 12 (5), pp. 735-50.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Print ISSN: 1354-3784 (Print)

Record details

×
Academic Journal

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy.

  • Authors : Movsesian MA; Cardiology Section, VA Salt Lake City Health Care System, 500 Foothill Boulevard, Salt Lake City, UT 84148, USA.; Alharethi R

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Cardiomyopathy, Dilated/Cardiomyopathy, Dilated/Cardiomyopathy, Dilated/*drug therapy ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*therapeutic use

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2002 Nov; Vol. 11 (11), pp. 1529-36.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Print ISSN: 1354-3784 (Print)

Record details

×
Academic Journal

Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease.

  • Authors : Giembycz MA; Thoracic Medicine, National Heart & Lung Institute, Imperial College School of Medicine, Dovehouse Street, London SW3 6LY, UK.

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*therapeutic use ; Lung Diseases, Obstructive/Lung Diseases, Obstructive/Lung Diseases, Obstructive/*drug therapy

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2001 Jul; Vol. 10 (7), pp. 1361-79.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Print ISSN: 1354-3784 (Print)

Record details

×
  • 1-5 of  5 results for ""Cyclic Nucleotide Phosphodiesterases, Type 3""